FDCTech, Inc. Files Restated Q3 2025 Financials: Key Restatement Items, Legal Updates, and Shareholder Impacts
FDCTech, Inc. (OTC: FDCT) has filed an Amendment No. 1 on Form 10-Q/A for the quarterly period ended September 30, 2025. This amendment restates previously issued consolidated financial statements and expands disclosures, including legal proceedings and changes affecting investor value. The restatement follows a Board of Directors decision, after consultation with management and the independent auditor, to conclude that prior unaudited financials for Q3 2025 should no longer be relied upon due to material errors.
Key Points and Price-Sensitive Information
- Restatement of Financial Statements: The company’s previously issued unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2025 contain errors and have been restated. Investors should note that the prior financials are no longer reliable.
- Principal Restatement Items:
- Reclassification of Subscription Receivable: Moved from current assets to a contra-equity account, affecting the balance sheet presentation and potentially impacting equity calculations.
- Recognition of Previously Unrecorded Shares: 500,000 shares of common stock issued in October 2021 were not previously recorded in the company’s share register. Their recognition corrects the share count and capital structure.
- Separate Presentation of Restricted Cash: Now disclosed as representing client funds segregated under regulatory requirements, which may affect liquidity ratios and regulatory compliance perceptions.
- Correction of Noncontrolling Interest Walk: Adjusted in accordance with ASC 810-10, which could impact how profits/losses are allocated between controlling and noncontrolling interests.
- Correction of Accumulated Other Comprehensive Income Allocation: Adjusted under ASC 220-10, affecting equity and potentially impacting book value per share.
- Reclassification of the AIL Acquisition: Now treated as a transaction between entities under common control under ASC 805-50, reflecting a change in accounting for the acquisition of AIL, as Mr. Gope S. Kundnani is involved in both entities.
- Other Adjustments: Corrections to other income (expense) and a \$31,000 revenue cut-off correction, directly impacting net income (loss) for the periods in question.
- Expanded Legal Proceedings Disclosure: The amendment broadens the discussion of legal matters, including those existing as of September 30, 2025, and developments through the filing date. This includes expanded details in the notes to the financial statements, Management’s Discussion and Analysis, and Legal Proceedings section—areas closely watched by investors for potential liabilities and risks.
- Concurrent Restatements Across Reports: Simultaneously, FDCTech has filed multiple amendments to annual (10-K) and quarterly (10-Q) reports for other periods to reflect consistent restatement adjustments and legal proceedings disclosures. This broad restatement effort underscores the scale and seriousness of the corrections.
- Share Count Update: As of June 8, 2026, the company reported 423,084,729 shares of Common Stock outstanding at a par value of \$0.0001. The accurate share count is crucial for investors tracking dilution, ownership percentages, and voting power.
- Regulatory Compliance and Controls: The amendment is accompanied by currently-dated certifications from the CEO and CFO as required under Sarbanes-Oxley Sections 302 and 906, affirming management’s responsibility for the accuracy of the amended report.
- Non-Accelerated Filer/Smaller Reporting Company/Emerging Growth Company Status: FDCTech continues to be classified as a non-accelerated filer, smaller reporting company, and emerging growth company. It is not a shell company.
- Forward-Looking Statements and Risks: The company cautions that forward-looking statements are subject to risks and uncertainties, and actual results may differ materially from those anticipated.
Implications for Shareholders
- Restatement Risk: The need for a restatement signals past material weaknesses in financial reporting and internal controls, which could impact investor confidence and the company’s valuation.
- Potential Impact on Share Price: The expanded legal proceedings and accounting changes could expose the company to new liabilities or signal unresolved compliance issues, which may be price sensitive.
- Transparency and Remediation: The company’s proactive restatement and expanded disclosures may help restore credibility, but also highlight past reporting deficiencies that investors must consider in their risk analysis.
What’s Next?
Investors should monitor subsequent filings and news for:
- Further legal developments or regulatory actions.
- Additional restatements or corrections.
- Management commentary on steps taken to remediate control weaknesses.
Summary Table of Restated Reports
- Amendment No. 2 to Annual Report on Form 10-K for FY 2024
- Amendment No. 2 to Annual Report on Form 10-K for FY 2025
- Amendment No. 2 to Quarterly Report on Form 10-Q for Q1 2025
- Amendment No. 1 to Quarterly Report on Form 10-Q for Q2 2025
- Amendment No. 1 to Quarterly Report on Form 10-Q for Q1 2026
This demonstrates the company’s extensive restatement effort across multiple periods.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the original SEC filings and consult with their financial advisors before making any investment decisions. The information herein is based on the most recent public filings as of June 8, 2026, and may not reflect subsequent events or corrections.
